Treatment of coronary artery disease in patients with renal failure

Nephrology Dialysis Transplantation

Volumn 15, Issue , 2000, Pages 117-121

  Rabelink, Ton J ^a   Truin, Gerben ^a   de Jaegere, Peter ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CREATINE KINASE MB; DOBUTAMINE; FIBRINOGEN RECEPTOR ANTAGONIST; LOW MOLECULAR WEIGHT HEPARIN; MYOGLOBIN; NITRATE; THROMBOCYTE RECEPTOR; TROPONIN I; TROPONIN T; VON WILLEBRAND FACTOR;

ANEMIA; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; ECHOCARDIOGRAPHY; HEART INFARCTION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PERITONEAL DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; UNSTABLE ANGINA PECTORIS;

CORONARY DISEASE; FIBRINOLYTIC AGENTS; HUMAN; KIDNEY FAILURE; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; THROMBOLYTIC THERAPY;

EID: 0033787078     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.suppl_5.117     Document Type: Article

References (54)

1. ACC/AHA guidelines for the management of patients with acute myocardial infarction
2. National academy of clinical biochemistry standards of laboratory Practice: Recommendations for the use of cardiac markers in coronary artery diseases
3. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
4. Coronary artery bypass surgery in patients on chronic hemodialysis
5. Cardiopulmonary bypass procedures in dialysis patients
6. Cardiac operations in patients with end-stage renal disease
7. Coronary artery bypass operation in dialysis
8. Outcome of dialysis patients receiving thrombolytic therapy for acute myocardial infarction in the United States
9. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis
10. Thrombosis and hemostasis in renal disease
11. Upper gastrointestinal bleeding in patients with chronic renal failure
12. Evidence-based recommendations for the clinical use of recombinant human erythropoietin
13. Appropriate hematocrit levels of erythropoietin supplementary therapy in end-stage renal failure complicated by coronary artery disease
14. Asymptomatic cardiac ischemia pilot (ACIP) study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization
15. Screening and treatment for cardiovascular disease in patients with chronic renal disease
16. Risks for renal dysfunction with cardiac angiography
17. Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents
18. Contrast nephropathy after coronary angioplasty in chronic renal insufficiendy
19. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patient undergoing cardiac angiography
20. Coronary artery bypass surgery: Risks and benefits, realistic and unrealistic expectations
21. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures
22. Coronary-artery surgery in patients with end-stage renal disease
23. Coronary artery bypass grafting in patients with dialysis-dependent renal failure
24. Mortality and results after cardiac surgery in patients with end-stage renal disease
25. Cardiac surgery for chronic renal dialysis patients
26. Cardiac surgery in patients with chronic renal disease
27. Coronary artery bypass grafting in dialysis patients
28. Cardiac operation and end-stage renal disease
29. Myocardial revascularization in patients on renal replacement therapy
30. Coronary artery bypass graft surgery in dialysis patients
31. Coronary artery bypass surgery in patients on maintenance dialysis: Long-term survival
32. Comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic hemodialysis patients
33. Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients
34. Increased morbidity after coronary angioplasty in patients on chronic hemodialysis
35. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients
36. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients
37. Outcome of coronary angioplasty (PTCA) versus coronary artery bypass surgery (CAB) in renal transplant patients in the United States
38. Coronary revascularization in patients on dialysis. What treatment option should we choose?
39. Cardiac surgery in patients with end-stage renal failure
40. Results of coronary artery bypass grafting in end-stage renal disease
41. Dialysis patients in the United States have better long-term outcomes with coronary artery bypass surgery compared to coronary angioplasty
42. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease
43. Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure
44. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty
45. Percutaneous transluminal coronary angioplasty
46. Restenosis after elective coronary balloon angioplasty in patients with end-stage renal disease
47. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
48. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
49. Effects of intervention with new devices on calcified coronary lesions in hemodialysis patients
50. Coronary stenting in ESRD patients
51. Long-term survival of dialysis patients in the United States after coronary artery bypass surgery, coronary angioplasty and coronary stenting
52. The evaluation of living renal transplant donors: Clinical practice guidelines
53. A comparison of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in patients on hemodialysis